Pathway-level Biomarkers
Pathway-Level Biomarkers is a type of biomarker that consists of functionally related sets of molecules organized within biological pathways, distinguished from molecular-level biomarkers by representing aggregated, systems-level alterations in pathway activity associated with a disease or biological state.
46
Publications
2.4K
Citations
536
Authors
197
Institutions
Publications per year
2017–2026
28
46
Giampaolo Bianchini, Astrid Kiermaier, Giulia Bianchi et al. · Breast Cancer Research · 2017 · 129 citations · Full text
Medicine, Oncology, Pharmacology +17
Towards natural mimetics of metformin and rapamycin
Alexander Aliper, Leslie C. Jellen, Franco Cortese et al. · Aging · 2017 · 118 citations · Full text
1–5 of 46
536
2
h-index
2
h-index
University of North Carolina at Chapel Hill, United States
2 publications · 65 citations
2
h-index
2
h-index
2
h-index
1–5 of 536
197
Massachusetts General Hospital
Boston, United States
4 h-index
7 publications
356 citations
Harvard University
Cambridge, United States
3 h-index
5 publications
248 citations
Northwestern University
Evanston, United States
2 h-index
15 publications
159 citations

Broad Institute
Cambridge, United States
2 h-index
7 publications
478 citations
Amgen (United States)
Thousand Oaks, United States
2 h-index
21 publications
1K citations
European Organisation for Research and Treatment of Cancer
Brussels, Belgium
2 h-index
3 publications
58 citations
Memorial Sloan Kettering Cancer Center
New York, United States
2 h-index
6 publications
478 citations

University of Colorado Denver
Denver, United States
2 h-index
5 publications
139 citations
1–8 of 197
2 publications · 48 citations
2
h-index
2 publications · 30 citations
2
h-index
2 publications · 94 citations
2
h-index
2 publications · 81 citations
2
h-index
2 publications · 45 citations
2
h-index
1–5